Pro Medicus Limited
PME
Classifica tra le azioni
#1628
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Prezzo delle azioni
$126.25
Capitalizzazione di mercato
$13.19B
Variazione (1 giorno)
-0.30%
Variazione (1 anno)
-32.46%
Paese
AU
Scambia Pro Medicus Limited (PME)
Categoria
Healthcare
Utile per Pro Medicus Limited (PME)
Utile nel Jun 2026 TTM: $266.26M
Secondo gli ultimi rapporti finanziari di Pro Medicus Limited, gli utili attuali della società sono $266.26M. Nel 2024, la società ha registrato un utile di $77.79M, un aumento rispetto a agli utili del 2023, che erano di $57.38M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Pro Medicus Limited dal 2000 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $266.26M | 147.66% |
| 2025 | $107.51M | 38.21% |
| 2024 | $77.79M | 35.55% |
| 2023 | $57.38M | 31.89% |
| 2022 | $43.51M | 35.35% |
| 2021 | $32.15M | 55.19% |
| 2020 | $20.71M | 12.91% |
| 2019 | $18.35M | 61.89% |
| 2018 | $11.33M | 9.72% |
| 2017 | $10.33M | 45.98% |
| 2016 | $7.07M | 79.75% |
| 2015 | $3.94M | 70.17% |
| 2014 | $2.31M | -151.63% |
| 2013 | $-4.48M | -530.12% |
| 2012 | $1.04M | 38.76% |
| 2011 | $750.57K | -84.46% |
| 2010 | $4.83M | -24.83% |
| 2009 | $6.42M | -40.86% |
| 2008 | $10.86M | 31.35% |
| 2007 | $8.27M | 29.34% |
| 2006 | $6.39M | 9.18% |
| 2005 | $5.86M | 68.01% |
| 2004 | $3.49M | -19.23% |
| 2003 | $4.32M | 13.36% |
| 2002 | $3.81M | 19.88% |
| 2001 | $3.18M | 2.97% |
| 2000 | $3.08M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $2.04B | 667.30% |
US
|
|
| $295.53M | 11.00% |
US
|
|
| $-259.89M | -197.61% |
US
|
|
| $-74.89M | -128.13% |
US
|
|
| - | - |
US
|
